These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


837 related items for PubMed ID: 19177031

  • 21. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.
    Ware N, MacPhee IA.
    Curr Opin Mol Ther; 2010 Jun; 12(3):270-83. PubMed ID: 20521216
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW.
    Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A.
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation.
    Imanishi Y, Matsui K, Ishida K, Ito S, Matsuura K, Deguchi T, Itoh Y.
    Arzneimittelforschung; 2011 Aug; 61(3):191-6. PubMed ID: 21528645
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
    Noll BD, Coller JK, Somogyi AA, Morris RG, Russ GR, Hesselink DA, Van Gelder T, Sallustio BC.
    Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Validation of sparse sampling strategies to estimate cyclosporine A area under the concentration-time curve using either a specific radioimmunoassay or high-performance liquid chromatography method.
    Koristkova B, Grundmann M, Brozmanova H, Perinova I, Safarcik K.
    Ther Drug Monit; 2010 Oct; 32(5):586-93. PubMed ID: 20683391
    [Abstract] [Full Text] [Related]

  • 34. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
    Coilly A, Calmus Y, Chermak F, Dumortier J, Duvoux C, Guillaud O, Houssel-Debry P, Neau-Cransac M, Stocco J.
    Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y, Takeuchi H, Okuyama K, Akashi T, Jojima Y, Konno O, Akashi I, Hama K, Iwahori T, Ashizawa T, Hirano T, Oka K, Matsuno N, Nagao T.
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Development of an ultra-performance liquid chromatography technique coupled with mass spectrometry for the measurement of tacrolimus in micro-samples of whole blood, and its application on a pharmacokiinetic trial.
    Marcelín-Jiménez G, García-González A, Angeles-Moreno AP, Contreras-Zavala L, Rivera L, Morales M.
    Arzneimittelforschung; 2007 May; 57(10):659-64. PubMed ID: 18074760
    [Abstract] [Full Text] [Related]

  • 38. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C, Seto W, Taylor T, Saunders EF, Doyle J, Dupuis LL.
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [Abstract] [Full Text] [Related]

  • 39. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
    Kuypers DR, Le Meur Y, Cantarovich M, Tredger MJ, Tett SE, Cattaneo D, Tönshoff B, Holt DW, Chapman J, Gelder Tv, Transplantation Society (TTS) Consensus Group on TDM of MPA.
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):341-58. PubMed ID: 20056756
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 42.